Evotec
Evotec and Bayer announce new kidney disease study
December 11, 2025Research and Development Bayer, Evotec, Nephrology
Evotec and Bayer have announced the initiation of a phase 2 clinical study in kidney disease, stemming from their previous …
Evotec shares progress in Bristol Myers Squibb neuroscience collaboration
June 12, 2024Research and Development Evotec, Neurology, bristol myers squibb, neuroscience
Evotec has announced that it has reached important scientific progress within the neuroscience collaboration with Bristol Myers Squibb, initiating a …
Evotec and Dewpoint Therapeutics enter strategic partnership
November 7, 2023Research and Development Dewpoint Therapeutics, Evotec, Oncology, R&D, oncology
Evotec and Dewpoint Therapeutics have announced a strategic R&D collaboration for the advancement of Dewpoint’s oncology pipeline programmes of condensate …
Exscientia enter first-ever AI cancer drug into Phase I trials
April 9, 2021Medical Communications AI, Evotec, Exscientia, cancer treatment, oncology, pharma, pharma news
Exscientia and Evotec have announced that they are entering an AI-designed immuno-oncology drug into Phase I trials for the first …
Evotec and Chinook to partner on new kidney disease treatments
March 1, 2021Sales and Marketing CKD, Chinook, Evotec, chronic kidney disease, kidney disease
Evotec and Chinook Therapeutics have agreed a deal to discover and develop new therapies for patients with chronic kidney diseases …
EvoTec to command vast Sanofi resources in infectious disease R&D partnership
March 8, 2018Research and Development, Sales and Marketing Evotec, Sanofi, infectious disease, infective disease, pharma
Sanofi has announced it is to team up with biotech drug discovery specialist EvoTec to leverage a new open innovation …
Sanofi, Evotec and Apeiron partner on immuno-oncology
August 10, 2015Research and Development, Sales and Marketing Apeiron, Cancer, Evotec, Sanofi, immuno-oncology, immunotherapy, tumours
Sanofi is partnering with biotech companies Evotec and Apeiron to develop new cancer immuno-oncology therapies.The companies say the potential new …
Evotec and Sanofi enter pre-clinical deal
December 3, 2014Research and Development, Sales and Marketing DiaPep277, Evotec, Sanofi, oncology, priftin, toulouse
Evotec and Sanofi have entered negotiations for a major multi-component strategic alliance worth around €250 million over the next five …
Trial misconduct halts Evotec/Hyperion drug
September 10, 2014Research and Development, Sales and Marketing DiaPep277, Evotec, amdromeda, diabetes, hyperion
Development of Evotec and Hyperion Therapeutic’s diabetes drug DiaPep277 has been terminated following ‘serious misconduct’ in one of its trials. …
arGEN-X appoints Evotec chief executive
April 14, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Evotec, arGEN-X, lanthaler
Belgium-based clinical stage human therapeutic antibody firm arGEN-X has appointed Dr Werner Lanthaler to its supervisory board.
 Lanthaler is currently …
Pharma losing in ‘valley of death’
February 21, 2013Research and Development, Sales and Marketing Bath, Evotec, pharma
An academic from Bath University has warned that much of pharma’s most promising research is being lost before it can …
Bayer signs endometriosis pact
October 3, 2012Research and Development, Sales and Marketing Bayer, Evotec, endometriosis
Bayer HealthCare and Evotec have signed a five-year deal to look for three novel drugs to treat women with endometriosis. …
Janssen buys into regenerative diabetes portfolio
July 11, 2012Research and Development, Sales and Marketing CureBeta, Evotec, Janssen, diabetes
Janssen has licensed a portfolio of drugs designed to regenerate insulin-producing beta cells. Janssen will receive exclusive access to a …
Roche and Evotec to develop Alzheimer’s drug
September 6, 2011Alzheimer's disease, Evotec, Roche
Roche and Evotec are to collaborate on the development and commercialisation of Evotec’s MAO-B inhibitor in patients with Alzheimer’s disease. …
Roche and Evotec to collaborate on cancer biomarkers
June 24, 2011Research and Development Evotec, Roche, biomarkers
Roche and Evotec are to collaborate to find biomarkers for Roche oncology drugs under development. Roche has been one of …
Latest content
Five Facts about cardiovascular disease
Artificial hearts: a century of innovation
